Effect of midkine on gemcitabine resistance in biliary tract cancer
Yongliang Lu
◽
Bing Yan
◽
Huihui Guo
◽
Li Qiu
◽
Xinrong Sun
◽
...
Goro Ueno
◽
Yoshifumi Iwagami
◽
Shogo Kobayashi
◽
Suguru Mitsufuji
◽
Daisaku Yamada
◽
...
Goro Ueno
◽
Yoshifumi Iwagami
◽
Shogo Kobayashi
◽
Suguru Mitsufuji
◽
Daisaku Yamada
◽
...
Goro Ueno
◽
Yoshifumi Iwagami
◽
Shogo Kobayashi
◽
Suguru Mitsufuji
◽
Daisaku Yamada
◽
...
2002 ◽
Vol 29
(6U)
◽
pp. 51-53
◽
J Harder
◽
O Waiz
◽
M Geissler
◽
HE Blum
◽
A Schmitt-Gräff
◽
...
C Mayr
◽
A Wagner
◽
D Neureiter
◽
M Pichler
◽
M Ritter
◽
...
Orphan designation: (5R,5aR,8aR,9S)-9-[[4,6-O-[(R)-Ethylidene]-β-D-glucopyranosyl]-oxy]-5-(4-({[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]carbonyl}oxy)-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one (etoposide toniribate), Treatment of biliary tract cancer
